Summary

This chapter has been an exhilarating odyssey through the multifaceted world of AI, finance, and biotechnology. We began with an exploration of GPT-4’s role in accelerating Moderna’s drug discovery. We ventured into the thrilling realm of momentum trading and the precision of Power BI visualizations. We also unveiled Moderna’s ambitious collaborations with IBM and Carnegie Mellon, their focus on combating cancer, future pandemics, and the innovative approach to outsourcing production. Next, we delved into the fascinating intersection of autonomous bots with Jarvis and HuggingGPT. We traced OpenAI’s journey toward AGI and the groundbreaking convergence of AI and quantum computing. Finally, we contemplated the ethical alignment of AGI, underscoring the importance of human values. This chapter has been a kaleidoscopic view of innovation, partnership, ambition, and ethical responsibility, setting the stage for what lies ahead.

In the last chapter...